Connor, Clark & Lunn Investment Management (CC&L)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.4M Sell
20,321
-3,538
-15% -$244K ﹤0.01% 962
2025
Q1
$1.66M Sell
23,859
-33,618
-58% -$2.33M 0.01% 784
2024
Q4
$4.94M Sell
57,477
-6,435
-10% -$554K 0.02% 485
2024
Q3
$7.61M Sell
63,912
-91,815
-59% -$10.9M 0.04% 338
2024
Q2
$22.2M Sell
155,727
-29,398
-16% -$4.2M 0.09% 175
2024
Q1
$23.8M Sell
185,125
-168,644
-48% -$21.7M 0.1% 179
2023
Q4
$36.6M Buy
353,769
+281,333
+388% +$29.1M 0.17% 115
2023
Q3
$6.59M Sell
72,436
-167,338
-70% -$15.2M 0.03% 330
2023
Q2
$19.4M Buy
239,774
+214,172
+837% +$17.3M 0.1% 159
2023
Q1
$2.04M Sell
25,602
-369,260
-94% -$29.4M 0.01% 547
2022
Q4
$26.7M Buy
394,862
+4,986
+1% +$337K 0.15% 111
2022
Q3
$19.4M Buy
389,876
+118,604
+44% +$5.91M 0.13% 123
2022
Q2
$15.1M Buy
271,272
+69,214
+34% +$3.86M 0.09% 160
2022
Q1
$11.2M Buy
202,058
+19,600
+11% +$1.09M 0.06% 213
2021
Q4
$10.2M Buy
182,458
+4,972
+3% +$278K 0.05% 240
2021
Q3
$8.52M Buy
177,486
+107,272
+153% +$5.15M 0.04% 267
2021
Q2
$2.94M Buy
+70,214
New +$2.94M 0.01% 462
2020
Q3
Sell
-238,240
Closed -$7.8M 1061
2020
Q2
$7.8M Sell
238,240
-679,370
-74% -$22.2M 0.06% 230
2020
Q1
$27.6M Sell
917,610
-270,800
-23% -$8.15M 0.25% 81
2019
Q4
$34.4M Buy
1,188,410
+667,350
+128% +$19.3M 0.24% 89
2019
Q3
$13.5M Buy
521,060
+104,100
+25% +$2.69M 0.09% 147
2019
Q2
$10.6M Sell
416,960
-260,250
-38% -$6.64M 0.07% 187
2019
Q1
$17.7M Buy
677,210
+403,000
+147% +$10.5M 0.12% 132
2018
Q4
$6.32M Sell
274,210
-411,238
-60% -$9.47M 0.04% 234
2018
Q3
$16.2M Buy
+685,448
New +$16.2M 0.09% 157
2018
Q1
Sell
-59,200
Closed -$1.59M 777
2017
Q4
$1.59M Buy
+59,200
New +$1.59M 0.01% 458
2017
Q2
Sell
-344,226
Closed -$5.9M 903
2017
Q1
$5.9M Buy
+344,226
New +$5.9M 0.04% 225